1. Intracellular pancreatic B cell serotonin and the dynamics of insulin release
- Author
-
M. L. de Bold, Olga Pulido, Sergio A. Bencosme, and A. J. de Bold
- Subjects
Male ,Serotonin ,medicine.medical_specialty ,Monoamine oxidase ,Tolbutamide ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Decarboxylase inhibitor ,Biology ,Fluorescence ,5-Hydroxytryptophan ,Islets of Langerhans ,Internal medicine ,Insulin Secretion ,Internal Medicine ,medicine ,Animals ,Insulin ,B cell ,Pancreatic islets ,Rats ,Glucose ,Endocrinology ,medicine.anatomical_structure ,Nialamide ,Intracellular ,medicine.drug - Abstract
The role of intracellular pancreatic B cell serotonin in the dynamics of insulin release was investigated in an in situ perfused rat pancreas preparation. Animals were pretreated with 5-hydroxytryptophan (5-HTP) to increase the intracellular levels of serotonin (5-HT) as shown by fluorescence histochemistry. Despite a clear induction of intracellular 5-HT fluorescence in pancreatic islets neither the pattern nor the total amount of insulin released were significantly modified after perfusion with either glucose or tolbutamide. However, the L-amino acid decarboxylase inhibitor, RO 4--4602, significantly decreased both phases of glucose-mediated insulin release in normal animals as well as in those receiving 5-HTP.
- Published
- 1978
- Full Text
- View/download PDF